Compare Citius Pharmaceuticals Inc (CTXR) vs Diageo plc (DEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Diageo plc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Diageo plc trades at $94.44 (market cap $53.05B). The key difference: Diageo plc is far larger — about 2651.2× Citius Pharmaceuticals Inc's market cap, and Diageo plc pays a 3.5% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | DEO | |
|---|---|---|
Market Cap | $20.01M | $53.05B |
Sector | Health | Technology |
52-Week High | $1.82 | $115.33 |
52-Week Low | $0.48 | $72.47 |
Enterprise Value | $16.23M | $72.54B |
Dividend Yield | — | 3.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
